About
CaeliVascular develops a multi-modal thrombectomy system designed to safely and completely remove large volume deep vein thrombosis (DVT) clots to improve treatment outcomes for venous obstructive disease and reduce risks such as pulmonary embolism.
Explore CaeliVascular's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.